Advertisement
Screener

RESHAPE LIFESCIENCES INC. Debt Conversion, Converted Instrument, Amount

RESHAPE LIFESCIENCES INC. Debt Conversion, Converted Instrument, Amount

RESHAPE LIFESCIENCES INC. reported Debt Conversion, Converted Instrument, Amount of $20.30 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-08.

Discontinued › Cash Flow › Financing Activities

us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2017-03-08

  • RESHAPE LIFESCIENCES INC. debt conversion, converted instrument, amount for the quarter ending 2016-12-31 was $17.10M.
  • RESHAPE LIFESCIENCES INC. debt conversion, converted instrument, amount for the quarter ending 2016-09-30 was $0.00.
  • RESHAPE LIFESCIENCES INC. debt conversion, converted instrument, amount for the quarter ending 2016-06-30 was $1.69M.
  • RESHAPE LIFESCIENCES INC. debt conversion, converted instrument, amount for the quarter ending 2016-03-31 was $1.51M.
  • RESHAPE LIFESCIENCES INC. debt conversion, converted instrument, amount for fiscal 2016 was $20.30M, a 20200.00% increase from fiscal 2015.
  • RESHAPE LIFESCIENCES INC. debt conversion, converted instrument, amount for fiscal 2015 was $100.00K.
Period endDebt Conversion, Converted Instrument, Amount 3 monthDebt Conversion, Converted Instrument, Amount 6 monthDebt Conversion, Converted Instrument, Amount 9 monthDebt Conversion, Converted Instrument, Amount 12 monthDebt Conversion, Converted Instrument, Amount 12 month as first filed
2016-12-31$17.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08
$17.10M
derived: sum of 2 quarters · filed 2017-03-08
$18.79M
derived: sum of 3 quarters · filed 2017-03-08
$20.30M
10-K · filed 2017-03-08
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$1.69M
derived: sum of 2 quarters · filed 2016-11-14
$3.20M
10-Q · filed 2016-11-14
2016-06-30$1.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12
$3.20M
10-Q · filed 2016-08-12
2016-03-31$1.51M
10-Q · filed 2016-05-10
2015-12-31$100.00K
10-K · filed 2017-03-08
$109.50K
10-K · filed 2016-03-28